Copyright
©2012 Baishideng Publishing Group Co.
World J Diabetes. Jan 15, 2012; 3(1): 7-18
Published online Jan 15, 2012. doi: 10.4239/wjd.v3.i1.7
Published online Jan 15, 2012. doi: 10.4239/wjd.v3.i1.7
Reduction of nitric oxide production |
Increased endothelin-1, prostaglandin E2 and thromboxane A2 |
Induction of growth factor expression: Transforming growth factor-β and vascular endothelial growth factor |
Accumulation of microvascular matrix, fibronectin and type IV collagen |
Overexpression of fibrinolytic inhibitor plasminogen activator inhibitor-1 |
Activation of the transcription factor nuclear factor kappa B |
Increased nicotinamide adenine dinucleotide phosphate oxidase activity |
Blood-flow abnormalities |
Alteration of vascular permeability |
Induction of angiogenesis |
Organ fibrosis |
Capillary occlusion |
Induction of inflammatory mediators |
Stimulation of oxidative stress |
- Citation: Luis-Rodríguez D, Martínez-Castelao A, Górriz JL, Álvaro F, Navarro-González JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes 2012; 3(1): 7-18
- URL: https://www.wjgnet.com/1948-9358/full/v3/i1/7.htm
- DOI: https://dx.doi.org/10.4239/wjd.v3.i1.7